基于四面体框架核酸的微RNA-155递送通过向Bcl-2/Bax亡途径缓解椎间盘退化
Zhuhai Li1,2, Yuanlin Tang3, Lihang Wang1,4
1Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, China.
Cell proliferation
|June 20, 2024
概括
与microRNA155 (TR155) 复合的四面体框架核酸 (tFNA) 在治疗椎间盘退化 (IDD) 方面表现有前途. TR155缓解IDD并抑制细胞亡,为慢性腰痛提供潜在的新疗法.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 分子生物学分子生物学
背景情况:
- 椎间盘退化 (IDD) 是慢性腰部疼痛的主要原因,有效治疗方法有限.
- 目前用于IDD的治疗方法主要是治疗症状,缺乏长期疗效.
- 四面体框架核酸 (tFNA) 是生物相容的纳米材料,具有抗亡和抗炎性质.
研究的目的:
- 研究一种新型TR155复合物的治疗潜力,用于治疗椎间盘退化 (IDD).
- 为了评估TR155对细胞核核细胞核的作用,在体外和体内.
- 探索TR155在缓解IDD和抑制细胞亡方面的潜在机制.
主要方法:
- 通过将microRNA155连接到tFNAs来合成TR155复合体.
- 在体外和体内对TR155对椎间盘退化模型的影响的评估.
- 通过Bcl-2/Bax途径对核脉细胞亡的分析.
主要成果:
- TR155复合体显著缓解了椎间盘变性.
- TR155有效地抑制了细胞核的细胞亡.
- 该机制涉及Bcl-2/Bax通路的调节.
结论:
- TR155显示出作为脊椎间盘退化症 (IDD) 的新疗法药物的潜力.
- 这项研究强调了TR155通过减少细胞亡来对抗IDD的能力.
- TR155代表了一种有前途的纳米药物策略,用于治疗与IDD相关的慢性腰痛.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K


